Home › Products › Oncology › Ceribulin 0.88mg Injection

Ceribulin 0.88mg Injection

Salt Composition: ERIBULIN

₹11828.00₹32856.56

Inclusive of all taxes

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Ceribulin 0.88 mg Injection contains eribulin, an anticancer medicine that belongs to the group of drugs known as antineoplastic agents. It is prescribed for adults with advanced breast cancer or liposarcoma (a cancer that develops in fatty tissues) when previous treatment options are no longer effective.

Do not use Ceribulin 0.88 mg Injection if you are allergic to eribulin or any of the other ingredients present in the medicine. Inform your healthcare provider if you suspect you may have an allergy to this medication. The safety and effectiveness of Ceribulin 0.88 mg Injection have not been established in children and adolescents under 18 years of age; therefore, its use is not recommended in this age group.

Before beginning treatment, tell your doctor if you have a history of fever, infections, liver disease, heart conditions, or any other significant medical problems. It is also important to provide your doctor with a complete medical history, including all prescription medicines, over-the-counter drugs, herbal products, and dietary supplements you are currently taking, to help ensure safe and effective treatment.

Uses

Advanced breast cancer Liposarcoma

How it works

Ceribulin 0.88mg Injection stops the growth and spread of cancer cells, specifically targeting the growth phase of microtubules, which are structures that help cells divide. It prevents them from growing without interfering with their shrinking phase. Additionally, it causes tubulin, a protein essential for cell division, to clump together in a way that disrupts cell division. This ultimately leads to the blockage of the cell cycle (G2/M phase), disrupting the formation of structures necessary for cell division (mitotic spindles) and triggering cell death through apoptosis.

How to Use

Ceribulin 0.88mg Injection will be given to you by your healthcare provider. It is injected directly into a vein (intravenous infusion) in a cycle. Your healthcare provider determines the dose, duration, and frequency based on your age, body weight, and severity of your condition. If you forget or miss your Ceribulin 0.88mg Injection cycle dose, make another appointment as soon as possible. Do not wait until your next planned visit. Do not stop the treatment without physician advice.

Side Effects

Side effects are unwanted symptoms that occur due to medicines. Even though all drugs cause side effects, not everyone gets them. Serious Sepsis (severe infection) Severe allergic reaction Serious skin conditions (Stevens-Johnson syndrome) Common Decrease in the number of white blood cells or red blood cells Tiredness or weakness Nausea, vomiting, constipation, diarrhea Numbness, tingling or prickling sensations Fever Loss of appetite, weight loss Difficulty breathing, cough Pain in the joints, muscles, and back Headache Hair loss

Expert Tips

Your doctor will monitor your liver function via blood tests and assess your heart function before and during treatment. If you are a woman who could become pregnant, ensure reliable birth control while taking Ceribulin 0.88mg Injection and for at least three months after stopping it. Consult your doctor for guidance on alternative contraception methods to avoid pregnancy during this treatment. Talk to your oncologist if you need dental treatment. Always tell your dentist you are having cancer treatment. This treatment can affect fertility in men and women. If you are worried about this, it is important to talk with your doctor before you start treatment. If you experience diarrhea while taking Ceribulin 0.88mg Injection, try to drink at least 2 liters of fluids daily and avoid alcohol, caffeine, milk products, and high-fat and high-fiber foods. If constipation occurs, increase your fluid intake, consume high-fiber foods, and engage in regular gentle exercise. Contact the hospital for advice; your doctor may prescribe laxatives to help constipation. If you notice a loss of appetite, don't worry if it lasts for a day or two, but if it persists or if you're losing weight, inform your nurse or dietitian for guidance. They may recommend supplements, dietary changes, or adjustments to eating habits to address these issues.

References

  1. Eisai Europe Limited, Electronic medicines compendium (EMC), [Revised on Jan 2023] [Accessed on Feb 2024], https://www.medicines.org.uk/emc/files/pil.4517.pdf
  2. Genentech, Inc, US Food and Drug Administration (FDA), [Revised on Jan 2016], [Accessed on Feb 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201532s015lbl.pdf
  3. Goodman & Gilman's Pharmacological Basis of Therapeutics, Pharmacotherapy of neoplastic drugs, 13th edition, 2018, 1187.

Safety Advice

Pregnancy: unsafe Ceribulin 0.88mg Injection is unsafe for pregnant women as it may cause fetal harm. Inform your doctor promptly if you are pregnant, planning for pregnancy, or think you may get pregnant before starting the treatment with Ceribulin 0.88mg Injection.

Lungs: Consult your doctor Ceribulin 0.88mg Injection can cause side effects like blood clots in the lungs and inflammation of the lungs. Inform your doctor if you have ever had lung disorders before starting the treatment, as its symptoms may worsen with Ceribulin 0.88mg Injection.

Breastfeeding: unsafe Ceribulin 0.88mg Injection is not recommended while breastfeeding since it is unknown whether it passes through breast milk. Inform your doctor if you are breastfeeding or planning to breastfeed before starting the treatment with Ceribulin 0.88mg Injection.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS